<DOC>
	<DOCNO>NCT00955474</DOCNO>
	<brief_summary>The purpose study compare efficacy tolerability Seroquel monotherapy treatment Major Depression Psychotic feature Seroquel plus Selective Serotonin Reuptake Inhibitor .</brief_summary>
	<brief_title>Seroquel Alone Versus Seroquel With SSRI Depression With Psychotic Symptoms</brief_title>
	<detailed_description>The propose study design investigate non-inferiority treatment PsyD use monotherapy quetiapine XR versus combination treatment use quetiapine XR SSRI ( sertraline citalopram escitalopram ) acute phase treatment . The primary outcome measure change rate symptom depression ( measure Hamilton Rating Scale Depression [ HAM-D-17 ] psychosis ( measure Brief Psychiatric Rating Scale [ BPRS ] Positive Symptoms Subscale ) . The secondary aim study assess safety efficacy combination quetiapine XR SSRIs patient diagnosis PsyD . Metabolic factor include fast glucose , fast insulin , fast lipid ( total cholesterol , HDL , LDL , triglyceride ) obtain screen 8-week endpoint study assess impact treatment development risk factor metabolic syndrome . Measures cognitive function ( MGH Cognitive Physical Functioning Questionnaire RBANS ) ( Fava et al . 2006 ; Randolph et al . 1998 ) obtain screen 8-week endpoint study assess impact treatment cognitive function .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Written inform consent 2 . Diagnosis Major Depressive Disorder Psychotic Features DSMIV 3 . Females Males age 1885 year . 4 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment 5 . Able understand comply requirement study 6 . Initial HAMD17 score &gt; 16 , screen visit baseline visit . 7 . Participants must initial BPRS score &gt; 25 least one following : &gt; 5 item 1 , &gt; 5 item 5 , &gt; 5 item 8 , &gt; 4 item 9 , &gt; 1 item 10 , &gt; 1 item 11 ; BPRS criterion msut meet screen visit baseline visit . 8 . Participants must initial CGI score &gt; 2 , screen visit baseline visit . 1 . Pregnancy lactation 2 . Any DSMIV Axis I disorder define inclusion criterion 3 . Patients , opinion investigator , pose imminent risk suicide danger self others 4 . Known intolerance lack response quetiapine fumarate , judge investigator 5 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir 6 . Use follow cytochrome P450 inducer 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoids 7 . Administration depot antipsychotic injection within one dose interval ( depot ) randomization 8 . Substance alcohol dependence within past three month ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion 9 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment 10 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment 11 . Unstable inadequately treat medical illness ( e.g . diabetes , angina pectoris , hypertension ) judge investigator 12 . Involvement plan conduct study 13 . Previous enrolment randomization treatment present study . 14 . Participation another drug trial within 4 week prior enrollment study long accordance local requirement 15 . A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrollment glycosylated hemoglobin ( HbA1c ) &gt; 8.5 % . Admitted hospital treatment DM DM relate illness past 12 week . Not physician care DM . Physician responsible patient 's DM care indicate patient 's DM control . Physician responsible patient 's DM care approve patient 's participation study Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior randomization . For thiazolidinediones ( glitazones ) period le 8 Weeks . Taking insulin whose daily dose one occasion past 4 week 10 % mean dose precede 4 week 16 . An absolute neutrophil count ( ANC ) 1.5 x 10^9 per liter 17 . Patients history seizure disorder ; unstable physical disorder ( cardiovascular , hepatic , renal , respiratory , endocrine , neurologic , hematologic ) ; physical disorder judge significantly affect central nervous system function . 18 . Patients currently treat antidepressant selective serotonin reuptake inhibitor , mood stabilize antipsychotic drug quetiapine . 19 . Patients know arrhythmias arrhythmia note screen EKG . 20 . Outpatients CGI score 7 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>